Literature DB >> 26700134

Primed to Understand Fibrinogen in Cardiovascular Disease.

Alisa S Wolberg1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26700134      PMCID: PMC4692188          DOI: 10.1161/ATVBAHA.115.306754

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  32 in total

1.  Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.

Authors:  Kevin R Siebenlist; Michael W Mosesson; Irene Hernandez; Leslie A Bush; Enrico Di Cera; John R Shainoff; James P Di Orio; Laurie Stojanovic
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

2.  NOTE ON THE ADSORPTION OF THROMBIN ON FIBRIN.

Authors:  W H Seegers; M Nieft; E C Loomis
Journal:  Science       Date:  1945-05-18       Impact factor: 47.728

Review 3.  The pleiotropic role of the fibrinogen gamma' chain in hemostasis.

Authors:  Shirley Uitte de Willige; Kristina F Standeven; Helen Philippou; Robert A S Ariëns
Journal:  Blood       Date:  2009-08-17       Impact factor: 22.113

4.  Resistance of gammaA/gamma' fibrin clots to fibrinolysis.

Authors:  L A Falls; D H Farrell
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

5.  Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin.

Authors:  E Dupuy; C Soria; P Molho; J M Zini; S Rosenstingl; C Laurian; P Bruneval; G Tobelem
Journal:  Thromb Res       Date:  2001-05-01       Impact factor: 3.944

6.  Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors.

Authors:  M N Mannila; R S Lovely; S C Kazmierczak; P Eriksson; A Samnegård; D H Farrell; A Hamsten; A Silveira
Journal:  J Thromb Haemost       Date:  2007-01-22       Impact factor: 5.824

7.  Thrombosis risk modification in transgenic mice containing the human fibrinogen thrombin-binding gamma' chain sequence.

Authors:  M W Mosesson; B C Cooley; I Hernandez; J P Diorio; H Weiler
Journal:  J Thromb Haemost       Date:  2008-10-30       Impact factor: 5.824

8.  Increased prothrombin activation in a patient with congenital afibrinogenemia is reversible by fibrinogen substitution.

Authors:  W Korte; A Feldges
Journal:  Clin Investig       Date:  1994-05

9.  Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Duke Appiah; Pamela J Schreiner; Richard F MacLehose; Aaron R Folsom
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-22       Impact factor: 8.311

10.  Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice.

Authors:  Kellie R Machlus; Jessica C Cardenas; Frank C Church; Alisa S Wolberg
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

View more
  2 in total

1.  Activated Monocytes Enhance Platelet-Driven Contraction of Blood Clots via Tissue Factor Expression.

Authors:  Alina D Peshkova; Giang Le Minh; Valerie Tutwiler; Izabella A Andrianova; John W Weisel; Rustem I Litvinov
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

2.  Reduced Contraction of Blood Clots in Venous Thromboembolism Is a Potential Thrombogenic and Embologenic Mechanism.

Authors:  Alina D Peshkova; Dmitry V Malyasyov; Roman A Bredikhin; Giang Le Minh; Izabella A Andrianova; Valerie Tutwiler; Chandrasekaran Nagaswami; John W Weisel; Rustem I Litvinov
Journal:  TH Open       Date:  2018-03-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.